Skip to main content
. 2017 Jun 13;8:129. doi: 10.3389/fendo.2017.00129

Table 1.

Clinical data of IGT patients and age-matched control subjects.

Control Patients with IGT
n 18 18
Sex (male/female) 9/9 9/9
Age (year) 56 ± 9 63 ± 11
Weight (kg) 79 ± 19 88 ± 17
Height (cm) 170 ± 11 168 ± 6
BMI (kg/m2) 27 ± 5 31 ± 6*
Systolic BP (mmHg) 130 ± 12 134 ± 17
Diastolic BP (mmHg) 81 ± 10 74 ± 9*
0 min glucose (mmol/l) 5.2 ± 0.4 6.0 ± 0.4**
120 min glucose (mmol/l) 5.5 ± 1.3 9.0 ± 1.0**
HbA1c (%) 5.4 ± 0.3 5.9 ± 0.4**

Values are represented as mean ± SD. Values are considered statistically significantly different at P < 0.05 (*), P < 0.0001 (**) compared with the control group.

IGT, impaired glucose tolerance; BMI, body mass index; BP, blood pressure; HbA1c, hemoglobin A1c.